Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) EBIT: 2013-2024

Historic EBIT for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $348.8 million.

  • Surgery Partners' EBIT rose 7356.32% to $105.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $406.4 million, marking a year-over-year increase of 2578.15%. This contributed to the annual value of $348.8 million for FY2024, which is 634.15% up from last year.
  • Surgery Partners' EBIT amounted to $348.8 million in FY2024, which was up 634.15% from $328.0 million recorded in FY2023.
  • Surgery Partners' EBIT's 5-year high stood at $348.8 million during FY2024, with a 5-year trough of $183.0 million in FY2020.
  • Over the past 5 years, Surgery Partners' median EBIT value was $328.0 million (recorded in 2023), while the average stood at $301.4 million.
  • In the last 5 years, Surgery Partners' EBIT crashed by 2242.48% in 2020 and then surged by 6513.66% in 2021.
  • Over the past 5 years, Surgery Partners' EBIT (Annual) stood at $183.0 million in 2020, then skyrocketed by 65.14% to $302.2 million in 2021, then grew by 14.23% to $345.2 million in 2022, then fell by 4.98% to $328.0 million in 2023, then increased by 6.34% to $348.8 million in 2024.
  • Its EBIT was $348.8 million in FY2024, compared to $328.0 million in FY2023 and $345.2 million in FY2022.